Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: A population based study^*

References

• Varma R, Ying-Lai M, Francis B, et al. Prevalence of open-angle glaucoma and ocular hypertension in Latinos. The Los Angeles Latino Eye Study. Ophthalmology 2004;111:1439-48
   PubMed Web of Science ®Google Scholar
• The Eye Diseases Prevalence Research Group. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol 2004;122:532-8
   PubMed Web of Science ®Google Scholar
• Collaborative normal-tension glaucoma study group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 1998;126:498-505
   PubMed Web of Science ®Google Scholar
• The AGIS Investigators. The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000;130:429-40
   Google Scholar
• Gordon M, Beiser J, Brandt J, et al. The ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:714-20
   PubMed Web of Science ®Google Scholar
• Leske M, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment. The early manifest glaucoma trial. Arch Ophthalmol 2003;121:48-56
   PubMed Web of Science ®Google Scholar
• Lichter P, Musch D, Gillespie B, et al. Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. Am J Ophthalmol 2001;108:1943-53
   Google Scholar
• Schwartz K, Budenz D. Current management of glaucoma. Curr Opin Ophthalmol 2004;15:119-26
   PubMedGoogle Scholar
• Alward W. Medical management of glaucoma. N Engl J Med 1998;339:1298-307
   PubMed Web of Science ®Google Scholar
• Soltau J, Zimmerman T. Changing paradigms in the medical treatment of glaucoma. Surv Ophthalmol 2002;47:S2-5
   PubMed Web of Science ®Google Scholar
• Semes L. Advances in glaucoma therapy. Optom Manage, 2006;41:94-8
   Google Scholar
• Balkrishnan R, Bond J, Byerly W, et al. Medication-related predictors of health-related quality of life in glaucoma patients enrolled in a Medicare health maintenance organization. Am J Geriatr Pharmacother 2003;1:75-81
   PubMedGoogle Scholar
• Kass M, Heuer D, Higginbotham E, et al. A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701-13
   PubMed Web of Science ®Google Scholar
• Covert D, Robin A, Novack G. Systemic medications and glaucoma patients. Ophthalmology 2005;112:1849.e1-1849.e2
   Web of Science ®Google Scholar
• Cellini M, Possati G, Caramazza N, et al. The use of flunarizine in the management of low-tension glaucoma: a color Doppler study. Acta Ophthalmol Scand Supplement 1997;224:57-8
   PubMedGoogle Scholar
• EGPS Group. Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study. Ophthalmology 2007;114:3-9
   PubMed Web of Science ®Google Scholar
• Hirooka K, Baba T, Fujimura T, et al. Prevention of visual field defect progression with angiotensin-converting enzyme inhibitor in eyes with normal-tension glaucoma. Am J Ophthalmol 2006;142:523-5
   Google Scholar
• Klein R, Knudtson M, Klein B. Statin use and the five-year incidence and progression of age-related macular degeneration. Am J Ophthalmol 2007;144:1-6
   PubMed Web of Science ®Google Scholar
• Langman M, Lancashire R, Cheng K, et al. Systemic hypertension and glaucoma: mechanisms in common and co-occurrence. Br J Ophthalmol 2005;89:960-3
   PubMed Web of Science ®Google Scholar
• McGwin Jr G, McNeal S, Owsley C, et al. Statins and other cholesterol-lowering medications and the presence of glaucoma. Arch Ophthalmol 2004;122:822-6
   PubMed Web of Science ®Google Scholar
• Miglior S, Torri V, Zeyen T, et al. Intercurrent factors associated with the development of open-angle glaucoma in the European Glaucoma Prevention Study. Am J Ophthalmol 2007;144:266-75
   PubMed Web of Science ®Google Scholar
• Punjabi O, Stamper R, Bostrom A, et al. Does treated systemic hypertension affect progression of optic nerve damage in glaucoma suspects?. Curr Eye Res 2007;32:153-60
   PubMed Web of Science ®Google Scholar
• Santafé J, Martinéz de Ibarreta M, Segarra J, et al. A long-lasting hypotensive effect of topical diltiazem on the intraocular pressure in conscious rabbits. Arch Pharmacol 1997;355:645-50
   Google Scholar
• Shah G, Sharma S, Mehta A, et al. Oculohypotensive effect of angiotensin-converting enzyme inhibitors in acute and chronic models of glaucoma. J Cardiovasc Pharmacol 2000;36:169-75
   PubMed Web of Science ®Google Scholar
• Shibuya T, Kashiwagi K, Tsukahara S. Comparison of efficacy and tolerability between two gel-forming timolol maleate ophthalmic solutions in patients with glaucoma or ocular hypertension. Ophthalmologica 2003;217:31-8
   PubMed Web of Science ®Google Scholar
• Song J, Deng P-F, Stinnett S, et al. Effects of cholesterol-lowering statins on the aqueous humor outflow pathway. Invest Ophthalmol Vis Sci 2005;46:2424-32.
   PubMed Web of Science ®Google Scholar
• Topouzis F, Coleman A, Harris A, et al. Association of blood pressure status with the optic disk structure in non-glaucoma subjects: The Thessaloniki Eye Study. Am J Ophthalmol 2006;142:60-7
   PubMed Web of Science ®Google Scholar
• van der Valk R, Webers C, Schouten J, et al. Intraocular pressure-lowering effects of all commonly used glaucoma drugs. A meta-analysis of randomized clinical trials. Ophthalmology 2005;112:1177-85
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Niwa Y, Kawakami H, et al. The effect of nilvadipine, a calcium-channel blocker, on the hemodynamics of retrobulbar vessels in normal-tension glaucoma. J Glaucoma 1998;7:301-5
   PubMed Web of Science ®Google Scholar
• RAMQ. Databank of official statistics on Quebec. Number of subscribers at age over 65 and under 65 [database]. Québec, Canada: Régie de l'assurance maladie Québec. Updated 24 May 2007
   Google Scholar
• Tamblyn R, Lavoie G, Petrella L, et al. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol 1995;48:999-1009
   PubMed Web of Science ®Google Scholar
• CPA. Compendium of Pharmaceuticals and Specialties (CPS). The Canadian Drug Reference for Health Professionals. Ottawa, Canada: Canadian Pharmacists Association, 2006
   Google Scholar
• AHFS. AHFS Pharmacologic-Therapeutic Classification (Table of Contents) [Online]. Available from American Hospital Formulary Service: Drug Information for 2006. Bethesda, MD: American Society of Health-System Pharmacists [Last accessed 27 November 2007]
   Google Scholar
• Klein B, Klein R, Knudtson M. Intraocular pressure and systemic blood pressure: longitudinal perspective: the Beaver Dam Eye Study. Br J Ophthalmol 2005;89:284-7
   PubMed Web of Science ®Google Scholar
• Müskens R, de Voogd S, Wolfs R, et al. Systemic antihypertensive medication and incident open-angle glaucoma. Ophthalmology 2007;114:2221-6
   PubMed Web of Science ®Google Scholar
• Gordon M, Beiser J, Kass M. Is a history of diabetes mellitus protective against developing primary open-angle glaucoma?. Arch Ophthalmol 2008;126:280-1
   PubMed Web of Science ®Google Scholar
• De M, Phan I, Bostrom A et al. Effect of statin and aspirin use on primary open-angle glaucoma progression. Investig Ophthalmol Vis Sci 2006;47;3398-B931. Available at http://abstracts.iovs.org/cgi/content/abstract/47/5/3398 [Last accessed 4 August 2008]
   Google Scholar
• De Castro D, Punjabi O, Bostrom A et al. Effect of statin drugs and aspirin on progression in glaucoma suspects. Investig Ophthalmol Vis Sci 2006;47;3399-B932. Available at http://abstracts.iovs.org/cgi/content/abstract/47/5/3399 [Last accessed 9 April 2008]
   Google Scholar